Smart science to improve lives™
Basket 0 View basket

Gain insights from our experts...

Optimizing lipid nanoparticles (LNPs) processing for siRNA delivery by microfluidics system

The success of mRNA vaccines during the COVID-19 pandemic has accelerated the advancement of nucleic acid delivery technologies. In addition to mRNA, interfering RNA offers potential to treat diseases beyond the reach of small molecules. However, therapeutic success hinges on efficient and targeted delivery systems. Lipid nanoparticles (LNPs), especially those produced via microfluidics, have emerged as a leading platform for RNA delivery. delivery. for RNA.  

Join Dr. Qiaobin Hu as he explores LNP formulation for siRNA delivery using a microfluidic flow-focusing system.  

Optimising lipid nanoparticles (LNPs) processing for siRNA delivery by microfluidics system

Croda Pharma Poster cover for Optimising lipid nanoparticles (LNPs) processing for siRNA delivery by microfluidics system
866.3 KB

Explore our poster presentation with Qiaobin Hu

Explore recent blogs:

Cell culture medium image

BioXPro™ high purity amino acids now available

Croda successfully launches new Amino Acid range BioXPro™: Croda International Plc (“Croda”) today confirms the successful introduction of its latest portfolio of high purity amino acids, developed to...
Chris Wells, Croda Pharma

Spotlight on Amino Acids with Christian Wells

This week we sat down with Christian Wells to discuss all things amino acids
Mo Pinto, Croda Pharma

Biologics Leaders: Mo Pinto

This week we sat down with Mo Pinto, one of our Biologics Leaders at Croda Pharma